Strategic Initiative

Slingshot members are tracking this corporate initiative:

Regeneron (REGN) and Alnylam (ALNY) Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Apr 08, 2019
Projected Implementation:
Q2, 2019
Relevance Tracked Until:
Q1, 2020
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Cns, Ocular Diseases, Rnai-based Therapy